A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer

Authors: Mohamed Omar, J. Chuck Harrell, Rulla Tamimi, Luigi Marchionni, Cihat Erdogan, Harikrishna Nakshatri, Tan A. Ince

Source: Breast Cancer Research, Vol 26, Iss 1, Pp 1-16 (2024)

Subject Terms: Breast cancer, Cell-of-origin, Triple hormone receptor, Estrogen receptor, Androgen receptor, Vitamin D receptor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1465-542X

Access URL: https://doaj.org/article/8a2eb70994dd4c63a4786f5a0770dfac